Cargando…

NAP (Davunetide): The Neuroprotective ADNP Drug Candidate Penetrates Cell Nuclei Explaining Pleiotropic Mechanisms

(1) Background: Recently, we showed aberrant nuclear/cytoplasmic boundaries/activity-dependent neuroprotective protein (ADNP) distribution in ADNP-mutated cells. This malformation was corrected upon neuronal differentiation by the ADNP-derived fragment drug candidate NAP (davunetide). Here, we inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ganaiem, Maram, Gildor, Nina D., Shazman, Shula, Karmon, Gidon, Ivashko-Pachima, Yanina, Gozes, Illana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527813/ https://www.ncbi.nlm.nih.gov/pubmed/37759476 http://dx.doi.org/10.3390/cells12182251

Ejemplares similares

Distinct Impairments Characterizing Different ADNP Mutants Reveal Aberrant Cytoplasmic-Nuclear Crosstalk
por: Ganaiem, Maram, et al.
Publicado: (2022)

The ADNP Derived Peptide, NAP Modulates the Tubulin Pool: Implication for Neurotrophic and Neuroprotective Activities
por: Oz, Saar, et al.
Publicado: (2012)

NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies
por: Ivashko-Pachima, Yanina, et al.
Publicado: (2019)

ADNP: in search for molecular mechanisms and innovative therapeutic strategies for frontotemporal degeneration
por: Gozes, Illana, et al.
Publicado: (2015)

ADNP, a Microtubule Interacting Protein, Provides Neuroprotection Through End Binding Proteins and Tau: An Amplifier Effect
por: Gozes, Illana, et al.
Publicado: (2018)

STOP Codon Mutations at Sites of Natural Caspase Cleavage Are Implicated in Autism and Alzheimer’s Disease: The Case of ADNP
por: Gozes, Illana, et al.
Publicado: (2022)

Discovery of autism/intellectual disability somatic mutations in Alzheimer's brains: mutated ADNP cytoskeletal impairments and repair as a case study
por: Ivashko-Pachima, Yanina, et al.
Publicado: (2019)

The ADNP Syndrome and CP201 (NAP) Potential and Hope
por: Gozes, Illana
Publicado: (2020)

A Novel Microtubule-Tau Association Enhancer and Neuroprotective Drug Candidate: Ac-SKIP
por: Ivashko-Pachima, Yanina, et al.
Publicado: (2019)

Corrigendum: A Novel Microtubule-Tau Association Enhancer and Neuroprotective Drug Candidate: Ac-SKIP
por: Ivashko-Pachima, Yanina, et al.
Publicado: (2021)

The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse
por: Sragovich, Shlomo, et al.
Publicado: (2019)

Microbiota changes associated with ADNP deficiencies: rapid indicators for NAP (CP201) treatment of the ADNP syndrome and beyond
por: Kapitansky, Oxana, et al.
Publicado: (2020)

Neuropeptide GPCRs in neuroendocrinology: the case of activity-dependent neuroprotective protein (ADNP)
por: Gozes, Illana
Publicado: (2012)

Activity-dependent neuroprotective protein (ADNP): from autism to Alzheimer’s disease
por: Gozes, Illana
Publicado: (2015)

Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein
por: Magen, Iddo, et al.
Publicado: (2014)

ADNP Regulates Cognition: A Multitasking Protein
por: Gozes, Illana
Publicado: (2018)

Single Cell ADNP Predictive of Human Muscle Disorders: Mouse Knockdown Results in Muscle Wasting
por: Kapitansky, Oxana, et al.
Publicado: (2020)

Unexpected gender differences in progressive supranuclear palsy reveal efficacy for davunetide in women
por: Gozes, Illana, et al.
Publicado: (2023)

VIP/PACAP-Based Drug Development: The ADNP/NAP-Derived Mirror Peptides SKIP and D-SKIP Exhibit Distinctive in vivo and in silico Effects
por: Sragovich, Shlomo, et al.
Publicado: (2020)

Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy
por: Gold, Michael, et al.
Publicado: (2012)

Preventive, personalized medicine at the level of key regulatory proteins: updates on activity-dependent neuroprotective protein (ADNP) as a case study
por: Gozes, Illana
Publicado: (2014)

NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy
por: Quraishe, S, et al.
Publicado: (2013)

The autism-mutated ADNP plays a key role in stress response
por: Sragovich, Shlomo, et al.
Publicado: (2019)

NAP and D-SAL: neuroprotection against the β amyloid peptide (1–42)
por: Gozes, Illana, et al.
Publicado: (2008)

Novel Marker for the Onset of Frontotemporal Dementia: Early Increase in Activity-Dependent Neuroprotective Protein (ADNP) in the Face of Tau Mutation
por: Schirer, Yulie, et al.
Publicado: (2014)

Cellular and animal models of skin alterations in the autism-related ADNP syndrome
por: Mollinedo, Pilar, et al.
Publicado: (2019)

Chromatin remodeler Activity-Dependent Neuroprotective Protein (ADNP) contributes to syndromic autism
por: D’Incal, Claudio Peter, et al.
Publicado: (2023)

Age and Sex-Dependent ADNP Regulation of Muscle Gene Expression Is Correlated with Motor Behavior: Possible Feedback Mechanism with PACAP
por: Kapitansky, Oxana, et al.
Publicado: (2020)

Premature primary tooth eruption in cognitive/motor-delayed ADNP-mutated children
por: Gozes, I, et al.
Publicado: (2017)

Premature primary tooth eruption in cognitive/motor-delayed ADNP-mutated children
por: Gozes, I, et al.
Publicado: (2017)

Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson’s disease
por: Melo, T. Q., et al.
Publicado: (2016)

Risperidone and NAP protect cognition and normalize gene expression in a schizophrenia mouse model
por: Vaisburd, Sinaya, et al.
Publicado: (2015)

Tauopathy in the young autistic brain: novel biomarker and therapeutic target
por: Grigg, Iris, et al.
Publicado: (2020)

Understanding Type 2 Diabetes Mellitus Risk Parameters through Intermittent Fasting: A Machine Learning Approach
por: Shazman, Shula
Publicado: (2023)

Activity-dependent neuroprotective protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer's pathologies
por: Malishkevich, A, et al.
Publicado: (2015)

Regulation of UV-B-Induced Inflammatory Mediators by Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) in Corneal Epithelium
por: Maugeri, Grazia, et al.
Publicado: (2023)

Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium
por: Maugeri, Grazia, et al.
Publicado: (2022)

Anti-Inflammatory Properties of NAP in Acute Toxoplasma Gondii-Induced Ileitis in Mice
por: Heimesaat, Markus M., et al.
Publicado: (2015)

Anti-inflammatory Effects of the Octapeptide NAP in Human Microbiota-Associated Mice Suffering from Subacute Ileitis
por: Escher, Ulrike, et al.
Publicado: (2018)

Classifying RNA-Binding Proteins Based on Electrostatic Properties
por: Shazman, Shula, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_kjqvj14umv6msf6hgkcj4pilge